---
{"dg-publish":true,"permalink":"/0-inbox/anticoagulant/","created":"2024-02-19T23:09:06.799+07:00","updated":"2025-10-06T19:39:57.764+07:00"}
---

![Coagulation Pathway.png](/img/user/3%20Resources/Attachment/Coagulation%20Pathway.png)

## Lab

| Class                       | Effects                                |
| --------------------------- | -------------------------------------- |
| Direct Thrombin Inhibitors  | Prolong TT<br>No effect on PT and aPTT |
| Direct Factor Xa Inhibitors | No effect on TT<br>Prolong PT and aPTT |
| Heparin                     | Prolong aPTT                           |

Thrombin Time (TT) -> Assess ability to convert fibrinogen to fibrin

Prothrombin Time (PT) -> Assess extrinsic + common pathway
- **measures how long it takes for a clot to form in a blood sample**

Partial thromboplastin time (aPTT) -> Assess intrinsic + common pathway 
- ค่าปกติอยู่ที่ 30-40 วินาที
- heparin -> 1.5 - 2.5 time baseline value -> 50-90 sec
- more than 100 sec = internal bleeding
- **reversal agents for heparin: protamine sulfate**

## Pharmacotherapy
![Pasted image 20240226174852.png|650](/img/user/3%20Resources/Attachment/Pasted%20image%2020240226174852.png)
![Pasted image 20240311113715.png|650](/img/user/3%20Resources/Attachment/Pasted%20image%2020240311113715.png)

- When to adjust OACs dosing?
    - Child A ไม่ต้องปรับถ้า B ไม่แนะนำ Rivaroxaban
    - ไต < 50 ml/min ปรับทั้ง 4 ตัว
    - ถ้าต่ำกว่า 30 ไม่แนะนำ Dabigatran
    - Apixaban มีเกณฑ์ age>= 80, bodyweight <=60kg, SCr >= 1.5mg/dl ถ้าเข้า 2 ใน 3 ให้ลดจาก 5.0 mg bid เหลือ 2.5 mg bid
    - Edoxaban ขับทางไตดีมาก ไม่ควรใช้ถ้า CrCl สูงแล้ว risk เยอะ
- DARE [#mnemonics](app://obsidian.md/index.html#mnemonics)
    - Dabigatran
        - 150 mg bid -> 110 mg bid if eGFR <= 50
    - Apixaban
        - 5 mg bid
        - reduce to 2.5 mg bid if 2 of this
            - age >= 80
            - wt <= 60
            - SCr >= 1.5 mg/dl
    - Rivaroxaban
        - 20 mg -> to 15 mg if eGFR < 50
    - Edoxaban
        - 60 mg -> 30 mg if eGFR < 50, wt <= 60 or P-gp inhibitor therapy
- NG Tube?
    - D -> NO, coated pellets inside capsule, removing capsule cause increase of F and increased bleeding
    - A -> YES
    - R -> YES
    - E -> YES
## Osmosis
![Pasted image 20240219231145.png|425](/img/user/3%20Resources/Attachment/Pasted%20image%2020240219231145.png)
Intrinsic factor start from circulating XII come in contact with Platelet or Collagen
- Fibrinogen -> **Thrombin (Factor IIa)** -> Fibrin (Ia) -> Fibrin Mesh
- Stabilizing Factor (XIII) -> Thrombin -> XIIIa + Calcium ion cofactors -> Cross-links

## Thrombin
- will activate platelets
- cause fibrinogen to turn into fibrin (1a) causing formation of fibrin mesh
- activate stabilizing factor (XIII) to XIIIa
- activate V (common pathway) and VIII (intrinsic pathway)
## Anti Thrombin III
- Inhibit Thrombin
- Inhibit Xa (Xa convert prothrom to thrombin)

## Heparin
### Unfractionated
- HMWH long tail
	- can increase anti thrombin III inhibiting activity of Xa
	- can increase anti thrombin III inhibiting activity of thrombin
	- heparin
	- rapid onsets, immediate anticoagulation

### Fractionated
- HMWH get depolymerized **-> เหลือแต่ LMWH**
	- LMWH short tail
	- can increase anti thrombin III inhibiting activity of Xa
	- enoxaparin, dalteparin
	- ไม่ต้องตาม lab เพราะไม่โดน thrombin
	- half-life นานด้วย
	- fondaparinux ก็คล้าย LMWH แต่มันสังเคราะห์ และมีแค่ penta saccharide chain

### Heparin induced thrombocytopenia
HIT Type 1 --> common เกิดได้ หายเองได้ ไม่ต้องหยุดยา  
HIT Type 2 --> immune mediated ให้หยุดยา แล้วหาอะไรแทน ไม่งั้น clot แน่
## Direct thrombin inhibitors
- Dabigatran (PO)
- Indication: 2nd line for DVT->PE prevention or AF->stroke prevention
- antidotes:
	- Dabigatran -> Idarucizumab
	- other agents: use prothrombin complex concentrate (PCC): contain II **VII** IX X, protein C & S or antifibrinolytic agents or transxemic acid
- bind to thrombin in circulation & already attached to clot
- should not be discontinued suddenyl

## Direct Xa inhibitors
- Prolong PT and aPTT
- Apixaban (PO), Edoxaban (PO), Rivaroxaban (PO)
- Treatment and prevention of VTE, PE and Stroke from AF
- Antidotes: Andexanet Alfa


 